• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较最小二乘回归法、贝叶斯法、邱氏法和稳态清除率法个体化茶碱剂量的准确性。

A comparison of the accuracy of a least squares regression, a Bayesian, Chiou's and the steady-state clearance method of individualising theophylline dosage.

作者信息

Hurley S F, McNeil J J

机构信息

Cancer Epidemiology Centre, Anti-Cancer Council of Victoria, Carlton South.

出版信息

Clin Pharmacokinet. 1988 May;14(5):311-20. doi: 10.2165/00003088-198814050-00003.

DOI:10.2165/00003088-198814050-00003
PMID:3396259
Abstract

We compared a least squares regression method, used prospectively to individualise the intravenous aminophylline and oral theophylline dosage of 48 patients, with 3 other pharmacokinetic methods - Chiou's, the steady-state clearance and the Bayesian - used retrospectively to analyse the same patient data. Methods were compared on the basis of the similarity of their parameter estimates and the accuracy with which serum concentrations during subsequent intravenous and oral therapy could be forecast, assuming each method's parameter estimates. The least squares and Bayesian programs were able to fit data from all but 4 and 2 patients, respectively. Mean absolute prediction errors were of the order of 20% for serum concentrations during intravenous therapy, and of the order of 40% for serum concentrations during oral therapy. The accuracy of the least squares, Bayesian and steady-state clearance methods were similar, but the accuracy of Chiou's method was comparable only when the 2 serum concentrations needed for the method were measured between 11 and 17 hours apart; an interval which corresponds to the 1.0 to 1.5 half-lives previously suggested as desirable for implementation of the Chiou method.

摘要

我们前瞻性地使用最小二乘回归法对48例患者的静脉注射氨茶碱和口服茶碱剂量进行个体化,并与其他3种药代动力学方法——邱氏法、稳态清除率法和贝叶斯法进行比较,这3种方法是对相同患者数据进行回顾性分析。比较方法基于其参数估计的相似性以及在假设每种方法参数估计的情况下,预测后续静脉和口服治疗期间血清浓度的准确性。最小二乘法和贝叶斯程序分别能够拟合除4例和2例患者之外的所有患者数据。静脉治疗期间血清浓度的平均绝对预测误差约为20%,口服治疗期间血清浓度的平均绝对预测误差约为40%。最小二乘法、贝叶斯法和稳态清除率法的准确性相似,但仅当邱氏法所需的两个血清浓度在间隔11至17小时测量时,邱氏法的准确性才相当;该时间间隔对应于先前建议实施邱氏法时理想的1.0至1.5个半衰期。

相似文献

1
A comparison of the accuracy of a least squares regression, a Bayesian, Chiou's and the steady-state clearance method of individualising theophylline dosage.比较最小二乘回归法、贝叶斯法、邱氏法和稳态清除率法个体化茶碱剂量的准确性。
Clin Pharmacokinet. 1988 May;14(5):311-20. doi: 10.2165/00003088-198814050-00003.
2
Evaluation of three theophylline dosing methods in pediatric patients.评估三种小儿患者茶碱给药方法。
DICP. 1991 Feb;25(2):179-85. doi: 10.1177/106002809102500213.
3
Evaluation of the Chiou method for determining theophylline dosages.用于确定茶碱剂量的邱氏方法的评估。
Clin Pharm. 1984 Mar-Apr;3(2):174-8.
4
Accuracy of 11 methods for predicting theophylline dose.11种预测茶碱剂量方法的准确性。
Clin Pharm. 1986 May;5(5):403-8.
5
The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.从静脉给药转换为口服治疗后口服缓释茶碱的给药设计。
Int J Clin Pharmacol Ther. 1994 Nov;32(11):625-31.
6
Adaptive control of theophylline therapy: importance of blood sampling times.茶碱治疗的自适应控制:采血时间的重要性。
J Pharmacokinet Biopharm. 1983 Oct;11(5):547-59. doi: 10.1007/BF01062211.
7
Reliability of theophylline clearance in determining chronic oral dosage regimens.茶碱清除率在确定慢性口服给药方案中的可靠性。
Am J Hosp Pharm. 1979 Jan;36(1):66-8.
8
Evaluation of a novel Bayesian method for individualizing theophylline dosage.一种用于个体化茶碱剂量的新型贝叶斯方法的评估。
J Clin Chem Clin Biochem. 1988 Jun;26(6):405-14. doi: 10.1515/cclm.1988.26.6.405.
9
Estimation of theophylline clearance during intravenous aminophylline infusions.静脉输注氨茶碱期间茶碱清除率的估算
J Pharm Sci. 1985 May;74(5):508-14. doi: 10.1002/jps.2600740504.
10
Bayesian derived predictions for twice daily theophylline under outpatient conditions and an assessment of optimal sampling times.门诊条件下每日两次茶碱的贝叶斯推导预测及最佳采样时间评估。
Br J Clin Pharmacol. 1989 Feb;27(2):215-21. doi: 10.1111/j.1365-2125.1989.tb05353.x.

引用本文的文献

1
Bayesian estimation of pharmacokinetic parameters: an important component to include in the teaching of clinical pharmacokinetics and therapeutic drug monitoring.药代动力学参数的贝叶斯估计:临床药代动力学教学和治疗药物监测中应纳入的重要组成部分。
Res Pharm Sci. 2020 Nov 27;15(6):503-514. doi: 10.4103/1735-5362.301335. eCollection 2020 Dec.
2
Identification of patients with impaired hepatic drug metabolism using a limited sampling procedure for estimation of phenazone (antipyrine) pharmacokinetic parameters.使用有限采样程序估算非那宗(安替比林)药代动力学参数以识别肝药物代谢受损患者。
Clin Pharmacokinet. 1993 Apr;24(4):333-43. doi: 10.2165/00003088-199324040-00006.
3

本文引用的文献

1
Rapid prediction of steady-state serum theophylline concentration in patients treated with intravenous aminophylline.静脉注射氨茶碱治疗患者稳态血清茶碱浓度的快速预测
Eur J Clin Pharmacol. 1980 Nov;18(6):473-7. doi: 10.1007/BF00874658.
2
A hand-held calculator program for individualized dosage adjustment of intravenous theophylline in acute asthma.一种用于急性哮喘患者静脉注射茶碱个体化剂量调整的手持式计算器程序。
Eur J Clin Pharmacol. 1980 May;17(5):393-9. doi: 10.1007/BF00558454.
3
Evaluation of two methods for estimating theophylline clearance prior to achieving steady state.
Pharmacokinetic optimisation of asthma treatment.
哮喘治疗的药代动力学优化
Clin Pharmacokinet. 1994 May;26(5):396-418. doi: 10.2165/00003088-199426050-00006.
4
The effect of respiratory disorders on clinical pharmacokinetic variables.呼吸系统疾病对临床药代动力学变量的影响。
Clin Pharmacokinet. 1990 Dec;19(6):462-90. doi: 10.2165/00003088-199019060-00004.
5
An updated comparison of drug dosing methods. Part II: Theophylline.药物给药方法的最新比较。第二部分:茶碱
Clin Pharmacokinet. 1991 Apr;20(4):280-92. doi: 10.2165/00003088-199120040-00003.
6
Bayesian estimation of doxorubicin pharmacokinetic parameters.
Cancer Chemother Pharmacol. 1991;29(1):53-60. doi: 10.1007/BF00686336.
7
Bayesian parameter estimation and population pharmacokinetics.
Clin Pharmacokinet. 1992 Jun;22(6):447-67. doi: 10.2165/00003088-199222060-00004.
在达到稳态之前评估两种估算茶碱清除率的方法。
Ther Drug Monit. 1981;3(4):325-32. doi: 10.1097/00007691-198104000-00002.
4
Some suggestions for measuring predictive performance.一些关于衡量预测性能的建议。
J Pharmacokinet Biopharm. 1981 Aug;9(4):503-12. doi: 10.1007/BF01060893.
5
Use of a pharmacokinetic method for establishing doses of aminophylline to treat acute bronchospasm.一种用于确定氨茶碱治疗急性支气管痉挛剂量的药代动力学方法的应用。
Am J Hosp Pharm. 1981 Jun;38(6):851-6.
6
Intraindividual variability in theophylline pharmacokinetics: statistical verification in 39 of 60 healthy young adults.
J Pharmacokinet Biopharm. 1982 Apr;10(2):123-34. doi: 10.1007/BF01062330.
7
Prediction of optimum oral theophylline dose in patients with obstructive airways disease.阻塞性气道疾病患者最佳口服茶碱剂量的预测
Br J Clin Pharmacol. 1983 Jun;15(6):689-94. doi: 10.1111/j.1365-2125.1983.tb01551.x.
8
Evaluation of the Chiou method for determining theophylline dosages.用于确定茶碱剂量的邱氏方法的评估。
Clin Pharm. 1984 Mar-Apr;3(2):174-8.
9
Comparison of three methods for estimating theophylline pharmacokinetics.三种估算茶碱药代动力学方法的比较
Clin Pharm. 1983 Mar-Apr;2(2):148-52.
10
Adaptive control of theophylline therapy: importance of blood sampling times.茶碱治疗的自适应控制:采血时间的重要性。
J Pharmacokinet Biopharm. 1983 Oct;11(5):547-59. doi: 10.1007/BF01062211.